Literature DB >> 3234475

The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.

G Edwards1, A Dingsdale, N Helsby, M L Orme, A M Breckenridge.   

Abstract

Administration of 12-mg doses of ivermectin (H2B1a) to 12 healthy volunteers in the form of tablets, capsules, and alcoholic oral solution showed the solution to have approximately twice the systemic availability as either of the solid forms, as evidenced both by the maximum concentrations of drug attained in plasma and by the corresponding areas under the plasma concentration vs time curves. However, the two solid formulations showed similar systemic availability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3234475     DOI: 10.1007/bf00637608

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Determination of ivermectin in human plasma and milk by high-performance liquid chromatography with fluorescence detection.

Authors:  R Chiou; R J Stubbs; W F Bayne
Journal:  J Chromatogr       Date:  1987-04-24

2.  Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis.

Authors:  A T White; H S Newland; H R Taylor; K D Erttmann; E Keyvan-Larijani; A Nara; M A Aziz; S A D'Anna; P N Williams; B M Greene
Journal:  J Infect Dis       Date:  1987-09       Impact factor: 5.226

3.  Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

Authors:  B M Greene; H R Taylor; E W Cupp; R P Murphy; A T White; M A Aziz; H Schulz-Key; S A D'Anna; H S Newland; L P Goldschmidt
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

4.  The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.

Authors:  K Awadzi; K Y Dadzie; H Shulz-Key; D R Haddock; H M Gilles; M A Aziz
Journal:  Ann Trop Med Parasitol       Date:  1985-02

5.  Pharmacokinetics of ivermectin administered intravenously to cattle.

Authors:  P K Wilkinson; D G Pope; F P Baylis
Journal:  J Pharm Sci       Date:  1985-10       Impact factor: 3.534

  5 in total
  21 in total

Review 1.  Pharmacotherapy of ectoparasitic infections.

Authors:  T C Roos; M Alam; S Roos; H F Merk; D R Bickers
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 3.  The pharmacokinetics and interactions of ivermectin in humans--a mini-review.

Authors:  Aránzazu González Canga; Ana M Sahagún Prieto; M José Diez Liébana; Nélida Fernández Martínez; Matilde Sierra Vega; Juan J García Vieitez
Journal:  AAPS J       Date:  2008-01-25       Impact factor: 4.009

Review 4.  Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.

Authors:  K L Goa; D McTavish; S P Clissold
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

5.  A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder.

Authors:  Daniel J O Roche; Megan M Yardley; Katy F Lunny; Stan G Louie; Daryl L Davies; Karen Miotto; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2016-04-18       Impact factor: 3.455

Review 6.  The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats.

Authors:  Erin J Campbell; Nathan J Marchant
Journal:  Br J Pharmacol       Date:  2018-02-26       Impact factor: 8.739

7.  Ivermectin levels in human breastmilk.

Authors:  J E Ogbuokiri; B C Ozumba; P O Okonkwo
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Ivermectin levels in human breast milk.

Authors:  J E Ogbuokiri; B C Ozumba; P O Okonkwo
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Ivermectin binds avidly to plasma proteins.

Authors:  U Klotz; J E Ogbuokiri; P O Okonkwo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Toxicity and potential utility of ivermectin and moxidectin as xenointoxicants against the common bed bug, Cimex lectularius L.

Authors:  Johnathan M Sheele; Gale E Ridge
Journal:  Parasitol Res       Date:  2016-04-18       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.